Biostarks launches at-home longevity test kits

Digital health company, Biostarks, has announced the launch of two new at-home test kits to measure a range of indicators for optimum health and longevity.

After entering the nutrition and sport markets with two respective at-home test kits leveraging its mass-spectrometry platform, the company is expanding its offering in the fast-growing longevity market with two new products in the space.

The base longevity at home test-kit, to be commercialised as early as of April 2023, measures intracellular NAD+ and three essential minerals.

The premium longevity at home test-kit covers more than 30 essential micronutrients across minerals, vitamins, fatty acids and amino acids, three hormone markers and intracellular NAD+. 

Biostarks has already undertaken new validation studies to expand the coverage of the test kit, with aim to provide comprehensive measurements for Senescence, Rapamycin levels and two markers of oxidative stress.

Both products pursue the promise of the company vision to provide innovative healthcare and wellness solutions which can be utilised at home, with a digital-first approach.

Francois Marland, executive Chairman of the company, commented: “We believe our premium longevity test-kit is a true novelty and market premiere for any individuals willing to decode their biodata and take a step towards a healthier lifespan.

“While the project is already funded internally, the commercial prelaunch is an awesome opportunity to engage with the longevity enthusiast’s community, to create broader awareness around at-home test kits solutions.”

In the coming quarter, the company is expected to undertake fundraising to accelerate its vision and further expand its offering in the corporate wellness space.

Premium longevity test-kits are available to preorder at www.biostarks.com/longevity/prelaunch ahead of the launch.